Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Valproic acid augments GABA-mediated postsynaptic inhibition in cultured mammalian neurons.

× No keyword cloud information.

22 in total

1. A water lick conflict paradigm using drug experienced rats.

Authors: E N Petersen; J B Lassen
Journal: Psychopharmacology (Berl) Date: 1981 Impact factor: 4.530

Review 2. Pharmacology of GABA-mediated inhibition of spinal cord neurons in vivo and in primary dissociated cell culture.

Authors: R L Macdonald; A B Young
Journal: Mol Cell Biochem Date: 1981-08-11 Impact factor: 3.396

3. Interactions of some anaesthetic, convulsant, and anticonvulsant drugs at GABA-benzodiazepine receptor-ionophore complexes in rat brain synaptosomal membranes.

Authors: J H Skerritt; G A Johnston
Journal: Neurochem Res Date: 1983-10 Impact factor: 3.996

4. Convulsant-induced depression of amino acid responses in cultured mouse spinal neurones studied under voltage clamp.

Authors: J L Barker; R N McBurney; D A Mathers
Journal: Br J Pharmacol Date: 1983-12 Impact factor: 8.739

Review 5. Effects of the antiepileptic drug valproate on metabolism and function of inhibitory and excitatory amino acids in the brain.

Authors: W Löscher
Journal: Neurochem Res Date: 1993-04 Impact factor: 3.996

6. "In vivo" administration of valproate decreases t-[35S]butylbicyclophosphorothionate binding in the rat brain.

Authors: A Concas; M P Mascia; E Sanna; G Santoro; M Serra; G Biggio
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1991-03 Impact factor: 3.000

7. Valproate attenuates accelerated atherosclerosis in hyperglycemic apoE-deficient mice: evidence in support of a role for endoplasmic reticulum stress and glycogen synthase kinase-3 in lesion development and hepatic steatosis.

Authors: Anna J Bowes; Mohammad I Khan; Yuanyuan Shi; Lindsie Robertson; Geoff H Werstuck
Journal: Am J Pathol Date: 2008-12-18 Impact factor: 4.307

Review 8. Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy.

Authors: Wolfgang Löscher
Journal: CNS Drugs Date: 2002 Impact factor: 5.749

9. Valproate as a treatment for dopamine dysregulation syndrome (DDS) in Parkinson's disease.

Authors: Ashok Sriram; Herbert E Ward; Anhar Hassan; Sanjay Iyer; Kelly D Foote; Ramon L Rodriguez; Nikolaus R McFarland; Michael S Okun
Journal: J Neurol Date: 2012-09-25 Impact factor: 4.849

10. Effects of short-term administration of valproate on serotonin-1A and dopamine receptor function in healthy human subjects.

Authors: Nicholas J Delva; Deborah L Brooks; Michael Franklin; Khalid al-Said; Emily R Hawken; Zul Merali; J Stuart Lawson; Arun V Ravindran
Journal: J Psychiatry Neurosci Date: 2002-11 Impact factor: 6.186